EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A detrimental role of endothelial S1PR2 in cardiac ischemia-reperfusion injury via modulating mitochondrial dysfunction, NLRP3 inflammasome activation, and pyroptosis

Yunhao Duan, Qinyu Li, Jinjin Wu, Caixia Zhou, Xiuxiang Liu, Jinnan Yue, Xiaoli Chen, Jie Liu, Qi Zhang, Yuzhen Zhang, Lin Zhang

Redox Biology · 2024

DOI: 10.1016/j.redox.2024.103244 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Redox Biology, 2024. Verfasst von Yunhao Duan und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cardiovascular Diseases and Medical Innovation Center, Shanghai East Hospital, School of Medicine, Tongji University, Shangha…. Hauptthemen laut MEDLINE: Endothelial Cells, Inflammasomes, Myocardial Reperfusion Injury, Sphingosine. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sphingosine 1-phosphate (S1P), a bioactive lipid molecule, exerts multifaceted effects on cardiovascular functions via S1P receptors, but its effects on cardiac I/R injury are not fully understood. Plasma lipidomics analysis by mass spectrometry revealed that sphingosine lipids, including sphingosine 1-phosphate (S1P), were significantly down-regulated following cardiac I/R injury in mice. The reduced S1P levels were also observed in the plasma of coronary heart disease (CHD) patients after percutaneous coronary intervention (PCI) compared with those without PCI. We found that S1P exerted a cardioprotective effect via endothelial cell (EC)-S1PR1, whereas EC-S1PR2 displayed a detrimental effect on cardiac I/R. Our data showed that EC-specific S1pr2 loss-of-function significantly lessened inflammatory responses and diminished cardiac I/R injury, while EC-specific S1pr2 gain-of-function aggravated cardiac I/R injury. Mechanistically, EC-S1PR2 initiated excessive mitochondrial fission and elevated ROS production via RHO/ROCK1/DRP1 pathway, leading to NLRP3 inflammasome activation and subsequent cell pyroptosis, thereby exacerbating inflammation and I/R injuries. Furthermore, RGD-peptide magnetic nanoparticles packaging S1pr2-siRNA to specifically knockdown S1PR2 in endothelial cells significantly ameliorated cardiac I/R injury. Taken together, our investigations demonstrate that EC-S1PR2 induces excessive mitochondrial fission, which results in NLRP3 inflammasome activation and subsequently triggers cell pyroptosis, ultimately exacerbating inflammatory responses and aggravating heart injuries following I/R.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endothelial CellsInflammasomesMyocardial Reperfusion InjurySphingosineSphingosine-1-Phosphate ReceptorsAnimalsHumansMaleMiceDisease Models, AnimalLysophospholipidsMitochondriaNLR Family, Pyrin Domain-Containing 3 ProteinPyroptosisReactive Oxygen Species

Stichwörter der Autor:innen

Cardiac I/REndothelial cellsInflammasomeMitochondriaPyroptosisS1pr2

Substanzen

InflammasomesLysophospholipidsNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mouseReactive Oxygen SpeciesS1PR2 protein, humanSphingosinesphingosine 1-phosphatesphingosine-1-phosphate receptor-2, mouseSphingosine-1-Phosphate Receptors

Autor:innen und Institutionen

  • State Key Laboratory of Cardiovascular Diseases and Medical Innovation Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China.
  • Department of Clinical Laboratory, Gongli Hospital of Shanghai Pudong New Area, 219 Miao Pu Road, Shanghai, 200135, China.
  • Department of Cardiology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
  • Department of Cardiology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China. Electronic address: zhangqnh@hotmail.com.
  • State Key Laboratory of Cardiovascular Diseases and Medical Innovation Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China. Electronic address: yzzhang-tj@tongji.edu.cn.
  • State Key Laboratory of Cardiovascular Diseases and Medical Innovation Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China; Clinical Center for Heart Disease Research, School o…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Duan, Y., Li, Q., Wu, J., Zhou, C., Liu, X., Yue, J., Chen, X., Liu, J., Zhang, Q., Zhang, Y., & Zhang, L. (2024). A detrimental role of endothelial S1PR2 in cardiac ischemia-reperfusion injury via modulating mitochondrial dysfunction, NLRP3 inflammasome activation, and pyroptosis. Redox Biology. https://doi.org/10.1016/j.redox.2024.103244

Vancouver

Duan Y, Li Q, Wu J, Zhou C, Liu X, Yue J, et al. A detrimental role of endothelial S1PR2 in cardiac ischemia-reperfusion injury via modulating mitochondrial dysfunction, NLRP3 inflammasome activation, and pyroptosis. Redox Biology. 2024. doi:10.1016/j.redox.2024.103244

BibTeX
@article{Duan2024,
  author = {Duan, Yunhao and Li, Qinyu and Wu, Jinjin and Zhou, Caixia and Liu, Xiuxiang and Yue, Jinnan and Chen, Xiaoli and Liu, Jie and Zhang, Qi and Zhang, Yuzhen and Zhang, Lin},
  title = {A detrimental role of endothelial S1PR2 in cardiac ischemia-reperfusion injury via modulating mitochondrial dysfunction, NLRP3 inflammasome activation, and pyroptosis},
  journal = {Redox Biology},
  year = {2024},
  doi = {10.1016/j.redox.2024.103244}
}
Kostenlos starten →